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High-M, (> 2 x 106) hyaluronic acid (about 82 pg/ml) was found for the first time in rabbit pericardial fluid. 
Biosynthetic experiments with minced pericardium from rabbit showed that the high-M, hyaluronic acid 
in the pericardial fluid was actively synthesized by the pericardium from [3H]glucosamine. 
Hyaluronic acid Pericardialjluid Pericardium (Rabbit) 
1. INTRODUCTION 
The functional roles of the pericardium and its 
pericardial fluid were confined to lubricating the 
moving surfaces of the heart and contributing 
mechanical support for the contraction of the ven- 
tricle [l]. However, we and other investigators 
have revealed that the pericardium is an active 
producer of prostacyclin and prostaglandins and 
plays an important role as extravascular source of 
prostacyclin in the pericardiac cavity [2-41. 
Little is known about which glycosaminoglycans 
exist in the pericardial fluid of the heart, although 
the chemical composition and the results of the 
analysis of the protein constituents and of elec- 
trolytes of the pericardial fluid have been reported 
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Abbreviations: CS, chondroitin sulfate; DS, dermatan 
sulfate; FCS, fetal calf serum; HS, heparan sulfate; 
MEM, Eagle’s minimum essential medium; ADi-4S, 
2-acetamido-2-deoxy-3-O-CB-D-gluco-4-enepyranosylu- 
ronic acid)-4-0-sulfa-D-galactose; ADi-6S, 2-acetamido- 
2-deoxy-3-0(&D-gluco-4-enepyranosyluronic a id)d-O- 
sulfo-D-galactose; ADi-OS, 2-acetamido-2-deoxy-3-0- 
V-D-gluco-4-enepyranosyluronic acid)-D-galactose 
We report here that glycosaminoglycans, 
especially high-M, hyaluronic acid (HA), were 
found for the first time in rabbit pericardial fluid 
and that the source of HA in the pericardial fluid 
was mainly pericardium. 
2. MATERIALS AND METHODS 
2. I . Materials 
The following commercial materials were used: 
MEM from Grand Island Biological, NY; FCS 
from Boehringer Mannheim, FRG; streptomycin 
sulfate from Meiji seika, Tokyo; penicillin from 
Banyu Pharmaceutical, Tokyo; D-[6-3H]glucos- 
amine hydrochloride (22.6 pCi/mmol) from the 
Radiochemical Center, Amersham; chondroitinase 
AC (EC 4.2.2.5) from Arthrobacter aureus, chon- 
droitinase ABC ( EC 4.2.2.4) from Proteus 
vulgaris, hyaluronidase (EC 4.2.2.1) from Strepto- 
myces hyalurolyticus, heparitinase (EC 4.2.2.8) 
from Flavobacterium heparinum, and ADi-4S, 
ADi-6S, and ADi-OS from Seikagaku Kogyo, 
Tokyo; pronase E (10’ PU/g; 1 PU = 1 mmol 
tyrosine/min) from Kaken Kagaku, Tokyo; Se- 
pharose CL-6B and CL-2B from Pharmacia, 
Uppsala; Toyo filter paper (no.SlA) from Toyo 
Roshi, Tokyo; Shodex standrd P-82 (Mr markers) 
from Showa Denko, Tokyo. 
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2.2. Preparation of rabbit pericardial fluid, 
plasma and pericardium 
Japanese white rabbits (3.0-3.5 kg) were 
anesthetized with sodium pentobarbital (39 mg/kg 
i.v.) and the pericardial fluid (250-300& ob- 
tained from the cardiac cavity with a plastic 
syringe. It was centrifuged at 500 x g for 5 min at 
4°C to remove any contamination of blood. About 
3 ml pericardial fluid was obtained from 9-12 
rabbits. 
Blood was obtained from the carotid of rabbit 
with a plastic tube. The blood was kept for 30 min 
at room temperature and then centrifuged at 
1000 rpm for 10 min. Plasma was separated and 
used for subsequent experiments. 
Pericardium (So-100 mg wet wt) was removed 
from the rabbit heart and placed in ice-cold 
sterilized saline and then minced with scissors. The 
minced pericardium was used for subsequent 
experiments. 
2.3. Incubation of pericardium 
The minced pericardium was washed twice with 
MEM and incubated in 2 ml MEM containing 
50 &i [6-3H]glucosamine in a flask under 5% CO2 
and 95% 02 at 37°C. After 4, 8 and 12 h incuba- 
tion, the medium (medium fraction) was removed 
from the flask and the pericardium (tissue frac- 
tion) rinsed with cold saline. 
2.4. Preparation and enzymic digestion of 
glycosaminoglycans 
Glycosaminoglycans from the pericardium fluid 
and medium and pericardium tissue were prepared 
after pronase digestion and cetylpyridinium 
chloride (CPC) treatment as described in [7]. 
Digestion with chondroitinase AC and chon- 
droitinase ABC [S], Streptomyces hyaluronidase 
[9], and heparitinase [lo] was described in previous 
papers. 
2.5. Descending paper chromatography 
The unsaturated disaccharides obtained from 
the isolated glycosaminoglycans by digestion with 
chondroitinase AC and ABC were spotted on Toyo 
no.SlA filter paper (20 x 40 cm). After desalting 
in butan-1-al/ethanol/water (13 : 8 : 4, by vol.) for 
48 h, descending paper chromatography was car- 
ried out in butan-1-al/acetic acid/l M ammonia 
(2 : 3 : 1, by vol.) for 24 h at room temperature [l 11. 
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The resulting paper was cut into 1 cm bands and 
the segments extracted with water. 
2.6. Gel chromatography 
Gel chromatography was carried out on a 
Sepharose CL-6B column (1.4 x 65 cm) or 
Sepharose CL-2B (1.15 x 66 cm). The column was 
equilibrated and eluted with 50 mM Tris-HCl buf- 
fer, pH 7.6, containing 0.15 M NaCl at a flow rate 
of 15 ml/h at 4°C. Fractions of 1.25 and 0.98 ml 
were collected in the case of Sepharose CLdB and 
Sepharose CL-2B, respectively, and assayed for 
radioactivity and uranic acid. 
2.7. Assay for radioactivity, uranic acid and 
protein 
Radioactivity was measured with a liquid scin- 
tillation counter (Aloka LSC-900), with 8 ml Scin- 
tisol EX-H (Wako, Tokyo) containing 0.5 ml sam- 
ple. The glycosaminoglycan content was deter- 
mined as uranic acid by the modified carbazole 
method of Bitter and Muir [12]. Protein content 
was determined by the method of Lowry et al. [ 131. 
3. RESULTS 
3.1. Characterization and identification of 
glycosaminoglycans in rabbit pericardial fluid 
and plasma 
The glycosaminoglycan concentration in rabbit 
pericardial fluid and plasma was determined as 
content of uranic acid @g/ml). The uranic acid 
content in the pericardial fluid (36.6 + 4.8 rg/ml, 
mean + SD for 3 experiments) was about 1Ctimes 
higher than that in plasma (2.6 + 0.2pg/ml, 
mean + SD for 3 experiments). However, the pro- 
tein content in plasma (50.5 + 2.5 mg/ml, mean f 
SD for 3 experiments) was about 2-times higher 
than that in the pericardial fluid (22.1 f 
1.9 mg/ml, mean f SD for 3 experiments). 
To characterize the molecular size of 
glycosaminoglycans obtained from rabbit pericar- 
dial fluid and plasma, gel chromatography on 
Sepharose CL-6B column was first carried out 
(fig. 1). The majority of glycosaminoglycans 
isolated from the pericardial fluid (about 90% of 
the uranic acid) was eluted in the void volume and 
most of the excluded peak was digested with Strep- 
tomyces hyaluronidase, suggesting that the major 
component of glycosaminoglycans in rabbit 
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Fig.1. Elution profiles of glycosaminoglycans in rabbit 
pericardial f uid and plasma on Sepharose CLdB. The 
glycosaminoglycans isolated from rabbit pericardial 
fluid and plasma were applied to a column (f .4 x 65 cm) 
of Sepharose CL-6B and eluted with 50 mM Tris-HCl 
buffer containing 0.15 M NaCl, pH 7.4. (a) Pericardial 
fluid (M), digested with Stfe~to~yces hyaluron- 
idase (O--O), (b) plasma (e----a). The arrows indicate 
(I’,-,) void volume and ( Vt) total volume. The recovery of 
glycosaminoglycans after gel chromatography was more 
than 90%. For further details, see text. 
pericardial fluid was HA. The profile of 
glycosaminoglycans i olated from pericardial fluid 
on Sepharose CL-6B was quite different from that 
of glycosaminoglycans isolated from plasma. 
These results suggest no cross-contamination of 
plasma glycosaminoglyc~s in the pericardial fluid 
prepared. When the glycosaminoglycans from 
pericardial fluid were further subjected to a 
Sepharose CL3B column, about 75% of the 
uranic acid was eluted in the void volume (fig.2). 
FRACTION No. 
Fig.2. Elution profile of glycos~inoglycans in rabbit 
pericardial fluid on Sepharose CL-2B. The 
glycosaminoglycans isolated from rabbit pericardial 
fluid were applied to a column (1.15 x 66 cm) of 
Sepharose CL-2B and eluted with 50 mM Tris-HCI 
buffer containing 0.15 M NaCl, pH 7.4. The arrows 
indicate (VO) void volume and (V,) total volume. The 
recovery of glycosaminoglycans after gel chromatog- 
raphy was more than 90%. For further details, see text. 
These results indicated that the major component 
of glycosaminoglycans in rabbit pericardial fluid 
was high-M, HA (n/l, > 2 x 106). 
The composition of glycosaminoglycans from 
the pericardial fluid and plasma was determined by 
descending paper chromatography of disac- 
charides obtained by the digestion of 
glycosaminoglycans with chondroitinase AC and 
ABC (table 1). More than 90% of 
glycosaminoglycans from the pericardial fluid was 
HA, while more than 85% of glycosaminoglycans 
from the plasma were CS and chondroitin low in 
sulfate. These results also indicated that the com- 
position of glycosaminoglycans in rabbit pericar- 
dial fluid was clearly different from that of 
glycosaminoglycans in plasma. 
Thus, we can calculate the concentration of the 
high-M, HA in the rabbit pericardial fluid as about 
82 ~gfml(O.O082%, w/v), since the real concentra- 
tion of HA is about 3-fold higher than the values 
of uranic acid (about 36.6yg/ml) as the index of 
the glycosaminoglycan concentration and the per- 
275 
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Table 1 
Composition of glycoaminoglycans in rabbit pericardial fluid and 
plasma 
HA HS DS cs 
ADi-4S ADi-6S ADi-OS 
Pericardial fluid 90.1 2.8 - 6.0 1.1 - 
Plasma 14.9 - - 34.2 5.9 45.0 
The glycosaminoglycans isolated from rabbit pericardial fluid and 
plasma were digested with chondroitinase AC and ABC. The digested 
mixture was desalted and subjected to descending paper 
chromatography as described in the text. The composition was 
calculated from the absorbance at 232 nm of the extracted spots 
corresponding to the unsaturated disaccharide standards (ADi-4S, 
ADi-6S, and ADi-OS). All values given are the mean of 3 experiments 
and are shown as percentage of total glycosaminoglycans 
FRACTlON No elution profile. For further details, see text. 
cent uranic acid at the void volume of Sepharose 
CL-2B is about 75%. 
3.2. Characteristics and biosynthesis of 
glycosaminoglycans by pericardium 
To determine where HA in the pericardial fluid 
was synthesized, minced rabbit pericardium was 
incubated in MEM containing [3H]glucosamine. 
The pericardium biosynthesized 3H-labeled 
glycosaminoglycans during incubation times up to 
12 h. When 3H-labeled glycosaminoglycans yn- 
thesized by the pericardium were subjected to a 
Sepharose CL-2B column, they were eluted in the 
Fig.3. Elution profiles of ‘H-labeled glycosamino- 
glycans biosynthesized in rabbit pericardium on Se- 
pharose CL-2B. The 3H-labeled glycosaminoglycans 
isolated from rabbit pericardium tissue and medium 
were applied to a column (1.15 x 66 cm) of Sepharose 
CL-2B and eluted with 50 mM Tris-HCl buffer con- 
taining 0.15 M NaCl, pH 7.4. (a) Pericardium tissue 
(o--o), digested with Streptomyces hyaluronidase 
(C--O), (b) medium (o--o), digested with Strepto- 
myces hyaluronidase (M). The arrows indicate (PO) 
void volume and (V,) total volume. The recovery of 
glycosaminoglycans after gel chromatography was more 
than 90%. The elution profile shown is from a sample 
after 4 h incubation. The elution profiles at different 
incubation periods (8 and 12 h) were similar to this 
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Table 2 
Composition of 3H-1abeled glycosaminoglycans biosynthesized in
rabbit pericardium 
HA HS DS CS 
ADi-4S ADi-6S ADi-OS 
Pericardium 92.7 1.6 - 2.7 1.8 1.2 
Medium 96.0 1.0 - 1.0 0.9 1.1 
The ‘H-labeled glycosaminoglycans isolated in pericardium tissue 
(about 80% of the total 3H radioactivity) and its medium (about 20% 
of the total 3H radioactivity) were digested with chondroitinase AC 
and ABC. The digestion mixture was applied to descending paper 
chromatography as described in the text. The composition of 
glycosaminoglycans was calculated from the ‘H radioactivity of the 
extracted spots corresponding to the unsaturated disaccharide 
standards (ADi-4S, ADi-6S, and ADi-OS). All values given are the 
mean of 3 experiments and are shown as percentage of ‘H total 
radioactivity 
July 1986 
void volume (fig.3). Most of the excluded peak was 
digested with Streptomyces hyaluronidase. This 
suggests that most of the IH-labeled glycosa- 
minoglycans biosynthesized by the pericardium 
was high-MI HA. 
The composition of 3H labeled glycosa- 
minoglycans biosynthesized was determined by 
descending paper chromatography of disac- 
charides obtained by chondroitinase AC and ABC 
digestion of ‘H-labeled glycosaminoglycans (table 
2). More than 92% of the 3H-labeled 
glycosaminoglycans was HA, the minor com- 
ponents being CS and HS. There was no signifi- 
cant difference in the components of radioactive 
glycosaminoglycans between the pericardium 
tissue and medium. In addition, supplementation 
of MEM with 10% FCS had no significant effect 
on the composition and M, of ‘H-labeled 
glycosaminoglycans produced by the pericardium 
(not shown). 
4. DISCUSSION 
The possibility that the pericardium might 
secrete some substance which lubricates the mov- 
ing surfaces of the heart has received little atten- 
tion. This work is the first demonstration of the 
occurrence of high-M, (>2 x 106) HA (about 
82 pg/ml) in the rabbit pericardial fluid (figs 1 and 
2, table 1). 
The biosynthesis experiments showed that the 
high-M, HA was actively synthesized by the 
pericardium from [3H]glucosamine (fig.3, table 2) 
and released into the pericardial fluid. When 
minced rabbit epicardium and myocardium were 
also incubated with [3H]glucosamine in some 
paired incubations, the total incorporation of ‘H 
into glycosaminoglycans in the epicardium and 
myocardium was about 30 and about 12%) respec- 
tively, as compared with that (100%) in the 
pericardium (not shown). Therefore, the high-MI 
HA can be considered to originate mainly in the 
pericardium, i.e. the serous parietal membranes 
which are lined with mesothelial cells [l], rather 
than an ultrafiltrate of blood serum. 
It is probable that the high& HA in the pericar- 
dial fluid could provide the heart tissue with 
resiliency and compliance when subjected to 
stretching or compressive forces. 
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